Of note, some H/IPAH patients have been described with heterozygous variants in EIF2AK4. However, it remains unclear whether these variants are a rare cause of AD PAH or potential genetic modifiers. This evidence concerns the gene EIF2AK4 and pulmonary arterial hypertension.